SCHEMBL3205236

SCHEMBL3205236

CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C/CC(CS)C(=O)OCC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 2/20 0.45
NR1I2 O75469 2/20 0.45
PTGS2 P35354 2/20 0.45
PGR P06401 1/20 0.45
PDE4D Q08499 1/20 0.45
CPB2 Q96IY4 1/20 0.44
ALDH1A1 P00352 7/20 0.43
CYP3A4 P08684 2/20 0.43
ALOX15 P16050 2/20 0.43
HSD17B10 Q99714 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
TSHR P16473 1/20 0.43
GRIK1 P39086 2/20 0.39
GRIK2 Q13002 2/20 0.39
CYP19A1 P11511 4/20 0.37
MAPT P10636 4/20 0.37
PPARG P37231 3/20 0.37
OXER1 Q8TDS5 3/20 0.37
RXRA P19793 2/20 0.37
FFAR1 O14842 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL441948 0.86 ADORA3 (0.47) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL3205311 0.86 ADORA3 (0.47) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL3205323 0.86 ADORA3 (0.47) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL444331 0.86 ADORA3 (0.47) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL27778350 0.86 ADORA3 (0.47) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL442023 0.86 ADORA3 (0.47) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL3696782 0.86 ADORA3 (0.47) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL16638877 0.83 ADORA3 (0.45) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL3220534 0.83 ADORA3 (0.45) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL3220525 0.83 ADORA3 (0.45) ADORA3NR1I2PTGS2PGRPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399516-B2 Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (PPAR) PRONOVA BIOPHARMA NORGE AS (NO) 2013-03-19 US disclosed
US-20100035990-A1 ALPHA-SUBSTITUTED OMEGA-3 LIPIDS THAT ARE ACTIVATORS OR MODULATORS OF THE PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR (PPAR) PRONOVA BIOPHARMA NORGE AS (NO) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035990-A1 ALPHA-SUBSTITUTED OMEGA-3 LIPIDS THAT ARE ACTIVATORS OR MODULATORS OF THE PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR (PPAR) PPARG, PPARA, FFAR3 ADORA3 201/4885NR1I2 143/4885PTGS2 228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.